These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.
    Author: Bongers V, de Klerk JM, Zonnenberg BA, de Kort G, Lips CJ, van Rijk PP.
    Journal: J Nucl Med; 1997 Jul; 38(7):1024-6. PubMed ID: 9225784.
    Abstract:
    Iodine-131-metaiodobenzylguanidine (MIBG) is used in the treatment of carcinoid tumors. Temporary palliation with complete subjective symptomatic response has been reported in these patients. This treatment is usually well tolerated and side-effects are generally limited to nausea, mild hepatic toxicity with spontaneous recovery and temporary myelosuppression. Our case report shows that repeated treatment with [131I]MIBG in a patient with extensive carcinoid liver metastasis may cause severe hepatic toxicity leading to death. Factors such as concomitant use of 5-fluorouracil and the progressive nature of the disease may have contributed to this event.
    [Abstract] [Full Text] [Related] [New Search]